[Guangdong, 1 November 2023] Hybribio is excited to announce its participation in the upcoming MEDICA 2023 taking place in Düsseldorf, Germany from 13th November to 16th November. 

MEDICA, as one of the largest medical B2B trade fairs worldwide, attracts over 5,500 exhibitors this year. It is renowned for bringing together a wide range of innovative products and services from the fields of medical imaging, laboratory technology, diagnostics, health IT, mobile health as well as physiotherapy/orthopaedic technology and medical consumables. This medical device festival is going to offer a unique platform for more than 81,000 visitors from all around the globe.

Visitors to Hybribio booth will have the chance to gain insights about cutting-edge molecular diagnostic solutions. As the top HPV DNA test producer in China, Hybribio is not only just showcasing a professional cervical cancer diagnostic solution, but also unveiling a range of molecular diagnostic reagents covering STDs, genetic diseases (thalassemia, G6PD, hearing Loss), methylation (bladder cancer, colorectal cancer, nasopharyngeal carcinoma), human cytomegalovirus, GBS, and etc. 

Booth information

No: 3K92-10

Location: Düsseldorf, Germany

Besides, Hybribio self-developed Fully Automated Sample Preparation Liquid Handling System HB-IEX96A, which integrates functions including decapping, recapping, tube loading, barcode scanning, nucleic acid extraction, and PCR setup, will make an appearance for the first time in Europe. It is designed to reduce human errors and improve PCR laboratory efficiency. 

Hybribio believes MEDICA 2023 is going to be a huge success. Looking forward to meeting you at MEDICA 2023. Your presence will make the event more meaningful!

About Hybribio

Hybribio is one of the pioneering biotech companies specialising in in-vitro diagnostic products with a fully integrated one-stop operation chain from R&D, manufacturing, sales & marketing to after-sales technical support services. Currently, we provide products and services to over 6000 hospitals and medical institutes in China. Our diagnostic reagents have been exported to nearly 30 countries. Working along with partners from different countries, our sales and marketing teams aim to provide an effective strategic marketing plan to suit different markets.

For more information about Hybribio and our products/services, please visit our website at www.hybribio.com.